1. Executive Summary
2. Europe – CGM User (2010 – 2024)
3. Europe – CGM Market & Forecast (2010 – 2024)
4. By Components – CGM Market (2010 – 2024)
4.1 Glucose Sensor Market & Forecast
4.2 CGM Transmitter Market & Forecast
5. Market Share – By Countries
6. Reimbursement Model – Europe CGM (Continuous Glucose Monitoring)
7. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)
8. United Kingdom – Diabetes Population (2010 – 2024)
8.1 Total Diabetes Population
8.1.1 Type 1 Diabetes Population
8.1.2 Type 2 Diabetes Population
9. United Kingdom - CGM Market & Forecast
9.1 United Kingdom - CGM Market by Components
9.1.1 Glucose Sensor Market & Forecast
9.1.2 CGM Transmitter Market & Forecast
10. United Kingdom – CGM User (2010 – 2024)
11. CGM Reimbursement in United Kingdom
12. Germany – Diabetes Population (2010 – 2024)
12.1 Total Diabetes Population
12.1.1 Type 1 Diabetes Population
12.1.2 Type 2 Diabetes Population
13. Germany - CGM Market & Forecast
13.1 Germany - CGM Market by Components
13.1.1 Glucose Sensor Market & Forecast
13.1.2 CGM Transmitter Market & Forecast
14. Germany – CGM User (2010 – 2024)
15. CGM Reimbursement in Germany
16. Netherlands – Diabetes Population (2010 – 2024)
16.1 Total Diabetes Population
16.1.1 Type 1 Diabetes Population
16.1.2 Type 2 Diabetes Population
17. Netherlands - CGM Market & Forecast
17.1 Netherlands - CGM Market by Components
17.1.1 Glucose Sensor Market & Forecast
17.1.2 CGM Transmitter Market & Forecast
18. Netherlands – CGM User (2010 – 2024)
19. CGM Reimbursement in Netherlands
20. Sweden – Diabetes Population (2010 – 2024)
20.1 Total Diabetes Population & Forecast
20.1.1 Type 1 Diabetes Population
20.1.2 Type 2 Diabetes Population
21 Sweden - CGM Market & Forecast
21.1 Sweden – CGM Market by Components
21.1.1 Glucose Sensor Market & Forecast
21.1.2 CGM Transmitter Market & Forecast
22. Sweden – CGM User (2010 – 2024)
23. CGM Reimbursement in Sweden
24. France – Diabetes Population (2010 – 2024)
24.1 Diabetes Population
24.1.1 Type 1 Diabetes Population
24.1.2 Type 2 Diabetes Population
25. France - CGM Market & Forecast
25.1 France - CGM Market by Components
25.1.1 Glucose Sensor Market & Forecast
25.1.2 CGM Transmitter Market & Forecast
26. France – CGM User (2010 – 2024)
27. CGM Reimbursement in France
28. Switzerland – Diabetes Population (2010 – 2024)
28.1 Total Diabetes Population
28.1.1 Type 1 Diabetes Population
28.1.2 Type 2 Diabetes Population
29. Switzerland - CGM Market & Forecast
29.1 Switzerland - CGM Market by Components
29.1.1 Glucose Sensor Market & Forecast
29.1.2 CGM Transmitter Market & Forecast
30. Switzerland – CGM User (2010 – 2024)
31. CGM Reimbursement in Switzerland
32. Growth Drivers
32.1 Continuous Positive Cost Effective Analysis by Several Countries
32.2 CGM Technology Convenient for both Patients & Physicians
33. Challenges
33.1 Controversy regarding Clinical Benefits
List of Figures:
Figure 2‑1: Europe – CGM User (Number), 2010 – 2017
Figure 2‑2: Europe – Forecast for CGM User (Number), 2018 – 2024
Figure 3‑1: Europe – CGM Market (Million US$), 2010 – 2017
Figure 3‑2: Europe – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 4‑1: Europe – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 4‑2: Europe – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 4‑3: Europe – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 4‑4: Europe – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 5‑1: Europe – CGM Market Share by Countries (Percent), 2010 – 2017
Figure 5‑2: Europe – Forecast for CGM Market Share by Countries (Percent), 2018 – 2024
Figure 7‑1: Abbott Freestyle Libre – User in Europe & Global (Number), May 2017
Figure 8‑1: United Kingdom: Diabetes Population (Thousand), 2010 – 2017
Figure 8‑2: United Kingdom: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 8‑3: United Kingdom: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 8‑4: United Kingdom: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 8‑5: United Kingdom: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 8‑6: United Kingdom: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 9‑1: United Kingdom – CGM Market (Million US$), 2010 – 2017
Figure 9‑2: United Kingdom – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 9‑3: United Kingdom – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 9‑4: United Kingdom – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 9‑5: United Kingdom – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 9‑6: United Kingdom – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 10‑1: United Kingdom – CGM User (Number), 2010 – 2017
Figure 10‑2: United Kingdom – Forecast for CGM User (Number), 2018 – 2024
Figure 12‑1: Germany: Diabetes Population (Thousand), 2010 – 2017
Figure 12‑2: Germany: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 12‑3: Germany: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 12‑4: Germany: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 12‑5: Germany: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 12‑6: Germany: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 13‑1: Germany – CGM Market (Million US$), 2010 – 2017
Figure 13‑2: Germany – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 13‑3: Germany – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 13‑4: Germany – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 13‑5: Germany – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 13‑6: Germany – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 14‑1: Germany – CGM User (Number), 2010 – 2017
Figure 14‑2: Germany – Forecast for CGM User (Number), 2018 – 2024
Figure 16‑1: Netherlands: Diabetes Population (Thousand), 2010 – 2017
Figure 16‑2: Netherlands: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 16‑3: Netherlands: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 16‑4: Netherlands: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 16‑5: Netherlands: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 16‑6: Netherlands: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 17‑1: Netherlands – CGM Market (Million US$), 2010 – 2017
Figure 17‑2: Netherlands – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 17‑3: Netherlands – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 17‑4: Netherlands – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 17‑5: Netherlands – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 17‑6: Netherlands – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 18‑1: Netherlands – CGM User (Number), 2010 – 2017
Figure 18‑2: Netherlands – Forecast for CGM User (Number), 2018 – 2024
Figure 20‑1: Sweden: Diabetes Population (Thousand), 2010 – 2017
Figure 20‑2: Sweden: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 20‑3: Sweden: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 20‑4: Sweden: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 20‑5: Sweden: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 20‑6: Sweden: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 21‑1: Sweden – CGM Market (Million US$), 2010 – 2017
Figure 21‑2: Sweden – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 21‑3: Sweden – Glucose Sensor Market (Million US$), 2010 -2017
Figure 21‑4: Sweden – Forecast for Glucose Sensor Market (Million US$), 2018 -2024
Figure 21‑5: Sweden – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 21‑6: Sweden – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 22‑1: Sweden – CGM User (Number), 2010 – 2017
Figure 22‑2: Sweden – Forecast for CGM User (Number), 2018 – 2024
Figure 24‑1: France – Diabetes Population (Thousand), 2010 – 2017
Figure 24‑2: France – Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 24‑3: France – Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 24‑4: France – Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 24‑5: France – Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 24‑6: France – Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 25‑1: France – CGM Market (Million US$), 2010 – 2017
Figure 25‑2: France – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 25‑3: France – Glucose Sensor Market (Million), 2010 – 2017
Figure 25‑4: France – Forecast for Glucose Sensor Market (Million), 2018 – 2024
Figure 25‑5: France – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 25‑6: France – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 26‑1: France – CGM User (Number), 2010 -2017
Figure 26‑2: France – Forecast for CGM User (Number), 2018 -2024
Figure 28‑1: Switzerland: Diabetes Population (Thousand), 2010 – 2017
Figure 28‑2: Switzerland: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 28‑3: Switzerland: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 28‑4: Switzerland: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 28‑5: Switzerland: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 28‑6: Switzerland: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 29‑1: Switzerland – CGM Market (Million US$), 2010 – 2017
Figure 29‑2: Switzerland – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 29‑3: Switzerland – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 29‑4: Switzerland – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 29‑5: Switzerland – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 29‑6: Switzerland – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 30‑1: Switzerland – CGM User (Number), 2010 – 2017
Figure 30‑2: Switzerland – Forecast for CGM User (Number), 2018 – 2024
List of Tables:
Table 6-1: Current Status of Global Real-Time Continuous Glucose Monitoring Coverage and Reimbursement, 2017
Table 7-1: Abbott Freestyle Libre vs. CGM
